In Sophie's work, she found that expanding NK cells transforms them to a highly cytotoxic subtype, hence serving the potential for cancer immunotherapy. Her work involved in vivo and in vitro studies, both with astonishing results. Read through her paper published in Cancer Immunology Research.
